ProjectR3500-AD-1798 – EINE RANDOMISIERTE, DOPPELBLINDE, PLACEBOKONTROLLIERTE PHASE-IIA-STUDIE ZUR BEWERTUNG DER…
Basic data
Acronym:
R3500-AD-1798
Title:
EINE RANDOMISIERTE, DOPPELBLINDE, PLACEBOKONTROLLIERTE PHASE-IIA-STUDIE ZUR BEWERTUNG DER WIRKSAMKEIT UND SICHERHEIT VON REGN3500 ALS MONOTHERAPIE UND REGN3500 IN KOMBINATION MIT DUPILUMAB BEI ERWACHSENEN PATIENTEN MIT MITTELSCHWERER BIS SCHWERER ATOPISCHER DERMATITIS
Duration:
02/04/2019 to 31/12/2020
Abstract / short description:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY TO ASSESS THE EFFICACY AND SAFETY OF REGN3500 MONOTHERAPY AND COMBINATION OF REGN3500 PLUS DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE
ATOPIC DERMATITIS
ATOPIC DERMATITIS
Keywords:
atopic dermatitis
Atopische Dermatitis
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
CRC-TR 156 - The Skin as a Sensor and Effector Organ Orchestrating Local and Systemic Immune Responses
Collaborative research centers and transregios
Collaborative research centers and transregios
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Tarrytown, New York, United States